Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 124 of 5804
-
New heart pump trial offers hope for End-Stage heart failure patients
Disease control OngoingThis study is to evaluate the safety and effectiveness of the Corheart 6 Left Ventricular Assist System (Corheart 6 LVAS) used for the treatment of end-stage heart failure.
Phase: NA • Sponsor: Shenzhen Core Medical Technology CO.,LTD. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Radioactive drug aims to shrink Hard-to-Treat gut tumors
Disease control OngoingThe purpose of the study is to evaluate the efficacy, safety \& patient-reported outcomes of peptide receptor radionuclide therapy (PRRT) with 177Lu-Edotreotide as 1st or 2nd line of treatment compared to best standard of care in patients with well-differentiated aggressive grade…
Phase: PHASE3 • Sponsor: ITM Solucin GmbH • Aim: Disease control
Last updated Jun 26, 2026 16:35 UTC
-
New drug shows promise in lung cancer with brain spread
Disease control OngoingThe study will compare the efficacy and safety of entrectinib with crizotinib in participants with advanced or metastatic ROS1 non-small cell lung cancer (NSCLC). The participants will self-administer oral entrectinib or crizotinib as described in the protocol and local prescribi…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Astrophysics meets dermatology: AI that maps moles like stars to catch melanoma early
Diagnosis OngoingMelanoma (skin cancer) frequently develops from existing moles on the skin. Current practice relies on expert dermatologists being able to successfully identify new/changing moles in individuals with multiple moles. Total body photography (TBP-high-quality images of the entire sk…
Phase: NA • Sponsor: Oxford University Hospitals NHS Trust • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
New device could fix leaky heart valves without Open-Heart surgery
Disease control OngoingThis is a postmarket clinical follow up study on the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System and the Edwards PASCAL Precision Transcatheter Valve Repair System in transcatheter tricuspid valve repair.
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Lung cancer combo therapy: does adding chemo to immunotherapy help?
Disease control OngoingPERSEE is a French national phase 3 academic study comparing the chemotherapy-pembrolizumab combination to pembrolizumab alone as a first-line treatment for advanced NSCLC molecularly defined by a PDL1 expression ≥ 50% of tumour cells and no EGFR mutations or ALK rearrangement. …
Phase: PHASE3 • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 26, 2026 17:38 UTC
-
Promising combo aims to keep stomach cancer at bay after surgery
Disease control OngoingThis is a Global Study of Neoadjuvant-Adjuvant Durvalumab or Placebo and FLOT Chemotherapy Followed by Adjuvant Durvalumab or Placebo in Patients with Resectable Gastric and Gastroesophageal Cancer (GC/GEJC) (MATTERHORN).
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Radiation-Chemo combo may let rectal cancer patients skip surgery
Disease control CompletedThe investigators' data from a phase I study of short course radiation therapy followed by chemotherapy showed 74% complete clinical response (cCR). Given the promising response rate, the investigators are evaluating short course radiation therapy (SCRT) followed by chemotherapy …
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Weekly shot may boost growth in kids with dwarfism
Disease control CompletedThe trial is a multicenter, double-blind, randomized, placebo-controlled, dose escalation trial of weekly TransCon CNP administered subcutaneously in prepubertal children 2 to 10 years old, inclusive, with Achondroplasia.
Phase: PHASE2 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Targeted pill combo could spare some breast cancer patients from chemo
Disease control OngoingAMBRE is a phase III study comparing two standard treatments as initial metastatic treatment in ER+/HER2- breast cancer (BC) patients with visceral metastasis and high burden disease: Chemotherapy and combination of endocrine therapy with abemaciclib.
Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a targeted drug boost standard therapy for a rare lymphoma?
Disease control OngoingThe purpose of this study is to see if the combination of rituximab and ibrutinib can help people with marginal zone lymphoma who have not received treatment in the past. The study will also compare the combination of rituximab and ibrutinib with the combination of rituximab and …
Phase: PHASE3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Engineered immune cells take on tough leukemia
Disease control Recruiting nowThis is a first-in-human, open-label, dose escalation and expansion study of UCART22 administered intravenously to patients with relapsed or refractory B-cell acute Lymphoblastic Leukemia (B-ALL). The purpose of this study is to evaluate the safety and clinical activity of UCART2…
Phase: PHASE1, PHASE2 • Sponsor: Cellectis S.A. • Aim: Disease control
Last updated Jun 26, 2026 14:53 UTC
-
Pharmacy-Based hepatitis c testing could cure more people on opioid therapy
Disease control CompletedHepatitis C Virus (HCV) is a blood-borne virus that damages the liver and is a major public health threat globally. Most individuals infected with HCV are unaware of it and show no symptoms until presenting with incurable, fatal end-stage disease. In Scotland and Australia approx…
Phase: NA • Sponsor: University of Dundee • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New pill could outshine chemo for common blood cancer
Disease control OngoingTo compare efficacy between zanubrutinib versus bendamustine and rituximab in patients with previously untreated CLL/SLL, as measured by progression free survival assess by Independent Central Review.
Phase: PHASE3 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Weekly shot could replace daily needles for kids with growth hormone deficiency
Disease control CompletedA 52 week trial of TransCon hGH, a long-acting growth hormone product, versus human growth hormone therapy. TransCon hGH will be given once-a-week, human growth hormone (hGH) will be given daily. Approximately 150 prepubertal, hGH-treatment naïve children (males and females) with…
Phase: PHASE3 • Sponsor: Ascendis Pharma Endocrinology Division A/S • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
HIV patients may ditch daily pills for monthly shots in landmark trial
Disease control OngoingThe Antiretroviral Therapy as Long Acting Suppression (ATLAS) study is being conducted to establish if human immunodeficiency virus type-1 (HIV-1) infected adult subjects with current viral suppression on a regimen with 2 nucleoside reverse transcriptase inhibitors (NRTIs) plus a…
Phase: PHASE3 • Sponsor: ViiV Healthcare • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Early HIV treatment may shield immune cells from lasting damage
Disease control OngoingThe purpose of this study is to identify and provide immediate antiretroviral therapy to a cohort of HIV-infected individuals with very early HIV infection (estimated date of infection within the last 90 days). The primary aim of the study is to evaluate whether initiation of dol…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Major trial tests whether skipping armpit surgery after sentinel node cancer is safe for breast cancer patients
Disease control OngoingSince the introduction of sentinel node biopsy in breast cancer, it has become clear that its use is reliable and reproducible. Today, it is clinical routine to not remove further lymph nodes from the axilla (arm pit) in case the sentinel node (which is the first lymph node/s rea…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New drug combo shows promise in slowing breast cancer growth
Disease control OngoingThe main purpose of this study is to evaluate how effective nonsteroidal aromatase inhibitors (NSAI) plus abemaciclib are in postmenopausal women with breast cancer. Participants will be randomized to abemaciclib or placebo in a 2:1 ratio.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could freezing replace the scalpel for some breast cancers?
Disease control CompletedTo evaluate the efficacy of cryoablation without lumpectomy and its impact on local and distant recurrence of early stage breast cancer .
Phase: NA • Sponsor: IceCure Medical Ltd. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC